Inhibition of the JAK2/STAT3 pathway in PTEN-deficient prostate tumors led to senescence-associated cytokine network reprogrammed, and improved the efficacy of docetaxel-induced senescence by triggering a strong anti-tumor immune response. Here, PTEN is linked to neoplasm.